FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2051260674> ?p ?o ?g. }

• W2051260674 endingPage "873" @default.
• W2051260674 startingPage "869" @default.
• W2051260674 abstract "Of 89 patients receiving nightly subcutaneous deferoxamine for transfusion-dependent thalassemia major or Diamond–Blackfan anemia, 13 presented with visual loss or deafness of acute onset or both. Detailed ophthalmologic, audiologic, and evoked-potential studies uncovered abnormalities caused by neurotoxicity in 27 more. Four patients with visual loss had optic neuropathy, with a marked decrease in acuity, loss of color vision, and delayed visual evoked potentials. Five asymptomatic patients had changes in the pigment of the retinal epithelium. The hearing loss was characterized by a high-frequency sensorineural deficit, which necessitated hearing aids in six patients. When deferoxamine was stopped, recovery of vision was complete in 2 patients and partial in 2, and in 22 patients with abnormal audiograms, reversal of the hearing deficit was complete in 4 and partial in 1. An analysis of the clinical data showed that members of the affected group were younger, had lower serum ferritin values, and were self-administering higher doses of deferoxamine per kilogram of body weight. Significantly lower doses of deferoxamine were being taken by patients without abnormalities than by those with visual symptoms, abnormal audiograms, or prolonged evoked potentials (P<0.001, <0.006, and <0.04, respectively). The data implicate high-dose deferoxamine as a central factor in the pathogenesis of the neurotoxicity. We strongly recommend careful regulation of the deferoxamine dosage and serial audiovisual monitoring in all patients receiving the drug. (N Engl J Med 1986; 314: 869–73.)" @default.
• W2051260674 created "2016-06-24" @default.
• W2051260674 creator A5005926392 @default.
• W2051260674 creator A5015039227 @default.
• W2051260674 creator A5033005105 @default.
• W2051260674 creator A5039800700 @default.
• W2051260674 creator A5042742297 @default.
• W2051260674 creator A5043684912 @default.
• W2051260674 creator A5051408582 @default.
• W2051260674 creator A5067753758 @default.
• W2051260674 creator A5076847093 @default.
• W2051260674 creator A5077706028 @default.
• W2051260674 creator A5078700478 @default.
• W2051260674 creator A5080739769 @default.
• W2051260674 date "1986-04-03" @default.
• W2051260674 modified "2023-09-26" @default.
• W2051260674 title "Visual and Auditory Neurotoxicity in Patients Receiving Subcutaneous Deferoxamine Infusions" @default.
• W2051260674 cites W1967672819 @default.
• W2051260674 cites W2002804406 @default.
• W2051260674 cites W2031683173 @default.
• W2051260674 cites W2061040652 @default.
• W2051260674 cites W2093425251 @default.
• W2051260674 cites W2118263150 @default.
• W2051260674 cites W2163004607 @default.
• W2051260674 cites W2165787958 @default.
• W2051260674 cites W2308456886 @default.
• W2051260674 cites W2346520058 @default.
• W2051260674 doi "https://doi.org/10.1056/nejm198604033141402" @default.
• W2051260674 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/3485251" @default.
• W2051260674 hasPublicationYear "1986" @default.
• W2051260674 type Work @default.
• W2051260674 sameAs 2051260674 @default.
• W2051260674 citedByCount "404" @default.
• W2051260674 countsByYear W20512606742012 @default.
• W2051260674 countsByYear W20512606742013 @default.
• W2051260674 countsByYear W20512606742014 @default.
• W2051260674 countsByYear W20512606742015 @default.
• W2051260674 countsByYear W20512606742016 @default.
• W2051260674 countsByYear W20512606742017 @default.
• W2051260674 countsByYear W20512606742018 @default.
• W2051260674 countsByYear W20512606742019 @default.
• W2051260674 countsByYear W20512606742020 @default.
• W2051260674 countsByYear W20512606742021 @default.
• W2051260674 countsByYear W20512606742022 @default.
• W2051260674 countsByYear W20512606742023 @default.
• W2051260674 crossrefType "journal-article" @default.
• W2051260674 hasAuthorship W2051260674A5005926392 @default.
• W2051260674 hasAuthorship W2051260674A5015039227 @default.
• W2051260674 hasAuthorship W2051260674A5033005105 @default.
• W2051260674 hasAuthorship W2051260674A5039800700 @default.
• W2051260674 hasAuthorship W2051260674A5042742297 @default.
• W2051260674 hasAuthorship W2051260674A5043684912 @default.
• W2051260674 hasAuthorship W2051260674A5051408582 @default.
• W2051260674 hasAuthorship W2051260674A5067753758 @default.
• W2051260674 hasAuthorship W2051260674A5076847093 @default.
• W2051260674 hasAuthorship W2051260674A5077706028 @default.
• W2051260674 hasAuthorship W2051260674A5078700478 @default.
• W2051260674 hasAuthorship W2051260674A5080739769 @default.
• W2051260674 hasConcept C118487528 @default.
• W2051260674 hasConcept C126322002 @default.
• W2051260674 hasConcept C141071460 @default.
• W2051260674 hasConcept C17743292 @default.
• W2051260674 hasConcept C187212893 @default.
• W2051260674 hasConcept C2776672577 @default.
• W2051260674 hasConcept C2777910003 @default.
• W2051260674 hasConcept C2778233873 @default.
• W2051260674 hasConcept C2779491297 @default.
• W2051260674 hasConcept C2780493683 @default.
• W2051260674 hasConcept C2780554537 @default.
• W2051260674 hasConcept C2780837183 @default.
• W2051260674 hasConcept C29730261 @default.
• W2051260674 hasConcept C42219234 @default.
• W2051260674 hasConcept C548259974 @default.
• W2051260674 hasConcept C71924100 @default.
• W2051260674 hasConceptScore W2051260674C118487528 @default.
• W2051260674 hasConceptScore W2051260674C126322002 @default.
• W2051260674 hasConceptScore W2051260674C141071460 @default.
• W2051260674 hasConceptScore W2051260674C17743292 @default.
• W2051260674 hasConceptScore W2051260674C187212893 @default.
• W2051260674 hasConceptScore W2051260674C2776672577 @default.
• W2051260674 hasConceptScore W2051260674C2777910003 @default.
• W2051260674 hasConceptScore W2051260674C2778233873 @default.
• W2051260674 hasConceptScore W2051260674C2779491297 @default.
• W2051260674 hasConceptScore W2051260674C2780493683 @default.
• W2051260674 hasConceptScore W2051260674C2780554537 @default.
• W2051260674 hasConceptScore W2051260674C2780837183 @default.
• W2051260674 hasConceptScore W2051260674C29730261 @default.
• W2051260674 hasConceptScore W2051260674C42219234 @default.
• W2051260674 hasConceptScore W2051260674C548259974 @default.
• W2051260674 hasConceptScore W2051260674C71924100 @default.
• W2051260674 hasIssue "14" @default.
• W2051260674 hasLocation W20512606741 @default.
• W2051260674 hasOpenAccess W2051260674 @default.
• W2051260674 hasPrimaryLocation W20512606741 @default.
• W2051260674 hasRelatedWork W173046059 @default.
• W2051260674 hasRelatedWork W177807439 @default.
• W2051260674 hasRelatedWork W1968023085 @default.
• W2051260674 hasRelatedWork W2007437790 @default.

• next